We use cookies in order to analyze traffic of this website. Your further use of this website will be considered consent. For more information visit our Cookie Policy.

SEC Filings

Form 6-K
AC IMMUNE SA filed this Form 6-K on 08/08/2018
Document Outline
Entire Document (808.4 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Subdocument 2 - EX-3.1 - EXHIBIT 3.1
Page 1 - Exhibit 3.1
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - ATTESTATION DE CONFORMIT
Subdocument 3 - EX-99.1 - EXHIBIT 99.1
Page 1 - Exhibit 99.1
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - Additional Information:
Page 6 - Statement of compliance
Page 7 - Critical judgments and accounting estimates
Page 8 - Going concern
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Subdocument 4 - EX-99.2 - EXHIBIT 99.2
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - Loss Per Share to Adjusted Loss Per Share
Page 8 - N/A
Subdocument 5 - EX-99.3 - EXHIBIT 99.3
Page 1 - Exhibit 99.3
Page 2 - Key Financial Data Unaudited (CHF million)
Page 3 - Research Development (R D) Expenses
Page 4 - Cash position
Page 5 - Reconciliation of Loss to Adjusted Loss and
Page 6 - About AC Immune